In order to evaluate the performance of PTDSS2, MRPL9, and SOCS2 as prognostic biomarkers, first, we verified the differential expression profiles of the three identified genes in HCC tissues and normal liver tissues in multiple HCC series of the GEO database. The gene discussed is PTDSS2; the disease is hepatocellular carcinoma.